GILEAD SCIENCES, INC. Logo

GILEAD SCIENCES, INC.

A research-based biopharmaceutical company focused on virology, oncology & inflammation.

GILD | US

Overview

Corporate Details

ISIN(s):
US3755581036
LEI:
Country:
United States of America
Address:
333 LAKESIDE DR, 94404 FOSTER CITY

Description

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-01 19:11
FORM 4
English ZIP 7.3 KB
2025-12-01 17:54
FORM 4
English ZIP 7.5 KB
2025-12-01 17:50
FORM 4
English ZIP 7.2 KB
2025-12-01 17:36
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 8.2 KB
2025-11-28 14:05 English ZIP 7.1 KB
2025-11-28 14:02 English ZIP 7.0 KB
2025-11-26 17:16 English ZIP 7.1 KB
2025-11-19 09:30
FORM 8-K
English ZIP 64.3 KB
2025-11-18 20:00
FORM 4
English ZIP 6.7 KB
2025-11-18 19:51
FORM 4
English ZIP 7.8 KB
2025-11-17 17:06 English ZIP 7.2 KB
2025-11-17 17:05 English ZIP 7.3 KB
2025-11-13 20:36
FORM 4
English ZIP 8.3 KB
2025-11-13 18:07 English ZIP 6.8 KB
2025-11-13 17:44 English ZIP 7.9 KB

Automate Your Workflow. Get a real-time feed of all GILEAD SCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GILEAD SCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GILEAD SCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes treatments for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
United Kingdom
AREC
argenx SE Logo
Develops and commercializes antibody-based therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
Clinical-stage biopharma developing oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Biotechnology company developing RNAi therapies to treat intractable diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops and commercializes needle-free products for administering therapies.
United States of America
SPRY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.